 |
 Sigma Onyx Fit Digitally Coded Heartrate Monitor NEW $69.49 Time Remaining: 5d 8h 59m Buy It Now for only: $69.49 |
 Sigma Heart Rate Monitor Onyx Classic Watch $29.99 Time Remaining: 7h 48m Buy It Now for only: $33.95 |
 SIGMA ONYX Classic Heart Rate Monitor Watch Topline $60.71 Time Remaining: 19d 13h 41m Buy It Now for only: $60.71 |
 Sigma Onyx Easy Digitally Coded Heart Rate Monitor Black Great Training Tool $76.90 Time Remaining: 12d 7h 51m Buy It Now for only: $76.90 |
 SIGMA ONYX Balance Heart Rate Monitor Watch 278500 1 UPC 750220285007 $60.71 Time Remaining: 28d 10h 57m Buy It Now for only: $60.71 |
 Sigma Onyx Easy heartrate monitor $45.00 Time Remaining: 1d 9h 42m |
 SIGMA ONYX EASY HEART RATE MONITOR WATCH $48.99 Time Remaining: 27d 23h 57m Buy It Now for only: $48.99 |
 SIGMA ONYX Balance Heart Rate Monitor Watch $66.00 Time Remaining: 4d 21h 19m Buy It Now for only: $66.00 |
Sigma Onyx
Oncology Market Forecast to 2015: Brand Spending and Development Opportunities
Chart the future of the global oncology market Explore the fiercely competitive oncology market with the most comprehensive resource available. Augment or build your models with deep, meticulously researched data - and expand your understanding of different drugs, classes and sub-classes.
Equip your team with 119 brand profiles, all of which contain painstaking detail :
- Historical and projected sales from 2006-2015
- Current and projected approvals
- Critical clinical trials to watch
- Analysis that places each drug in context against key competitors and market events
- Patent, generics and litigation information
After scouring the profiles, gauge your resource levels: Brand spending data tracks real-world dollars for promotion, medical affairs, market access and more - information you won't find anywhere else.
Give your teams all the oncology market research they need to make critical product decisions!
Additional Information :
Profiled Oncology Portfolios :
Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly (including ImClone), Genzyme, GlaxoSmithKline, Johnson & Johnson, Merck (including Schering-Plough), Novartis, Pfizer (including Wyeth), Roche (including Genentech), Sanofi-Aventis
All Companies Included in Report :
Abbott, Abraxis, Allos Therapeutics, Amgen, AnGes, Antisoma, Ariad, ArQule, Array BioPharma, Astellas, AstraZeneca, Bayer, Bioenvision, Biovail, Bristol-Myers Squibb, Celgene, Cephalon, Chugai, Cougar, Daiichi Sankyo, Dendreon, Eisai, Eli Lilly, Enzon, Epicept, Exelixis, GenMab, Genzyme, GlaxoSmithKline, GTx, Infinity, Johnson & Johnson, Medivation, Merck, Merck KGaA, Millennium, Myriad, Nektar, Novartis, Oncothyreon, Onyx, OSI, Pfizer, PharmaMar, Poniard, Progenics, Regeneron, Roche, Sanofi-Aventis, Seattle Genetics, Sigma Tau, Taisho, Transgene, Vical
For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3306/Oncology-Market-Forecast-to-2015-Brand-Spending-and-Development-Opportunities.html
or email us your query at : info@visionshopsters.com
----------------------------------------------
About the Author
VisionShopsters.com specializes in providing comprehensive collection of online market research reports, conference/events/seminars bookings, country reports, company profiles, latest books and magazines, customized research services offering informative solutions worldwide.
sigma-sport-pulsmetr-onyx-fit.MOV